Actively Recruiting

Age: 40Years - 70Years
All Genders
NCT07532863

A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants

Led by Novo Nordisk A/S · Updated on 2026-04-16

400

Participants Needed

1

Research Sites

15 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of the study is to investigate the cardiovascular disease (CVD) risk profile among participants newly diagnosed with type 2 diabetes mellitus (T2DM) in Southeast Asia (CRISTAL SEA). It's a retrospective chart-review across five Southeast Asian countries to characterize newly diagnosed T2DM participants and how their CVD risk is distributed, using data from the year before diagnosis and roughly the first year after diagnosis.

CONDITIONS

Official Title

A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants

Who Can Participate

Age: 40Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged greater than or equal to 40 and less than 70 years
  • Male or female
  • Newly diagnosed with type 2 diabetes mellitus and started anti-hyperglycemic treatment between 1 January 2022 and 31 December 2023
Not Eligible

You will not qualify if you...

  • Diagnosis of type 1 diabetes or gestational diabetes
  • Use of any anti-hyperglycemic medication before first diagnosis of type 2 diabetes mellitus
  • Pregnant women
  • Pre-existing atherosclerotic cardiovascular disease including coronary heart disease, stroke, transient ischemic attack, or peripheral artery disease
  • Death within 12 months after first diagnosis of type 2 diabetes mellitus
  • Lost to follow-up with no visit 12 months (±3 months) after first diagnosis of type 2 diabetes mellitus

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Novo Nordisk Investigational Site

Singapore, Singapore

Actively Recruiting

Loading map...

Research Team

N

Novo Nordisk

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here